The US FDA has approved CSL's HEMGENIX (etranacogene dezaparvovec-drlb) as the first and only one-time gene therapy for appropriate adults with haemophilia B. …
CSL secures US approval for breakthrough one-time haemophilia gene therapy
November 24, 2022 Latest NewsBioPharma
Latest Video
New Stories
-
CSL opens its new 'Australian Plasma Fractionation Facility' in Melbourne
December 8, 2022 - - Latest News -
Next year will be even tougher unless the downward trajectory can be halted
December 8, 2022 - - Latest News -
Construction is officially underway at Moderna's mRNA site
December 8, 2022 - - Latest News -
Catholic Health Australia calls for reform of premium approval process
December 7, 2022 - - Other Health -
AMA says new data reveals a worsening hospital logjam
December 7, 2022 - - Other Health -
GSK's Michelle Strong on the journey towards 'the end of this chapter'
December 7, 2022 - -
Another bad day for Pharmac with Ombudsman to investigate document release
December 7, 2022 - - Latest News